Skip to main content
24 November 2024
Last updated:
Friday 22 November 2024
User account anon menu
Login
Register and subscribe
Search
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form
Menu
Breadcrumb
Home
Strategy
Strategy
Leyden Labs plans to protect against viral infections
Read more
How exchange traded funds could benefit Europe
Read more
New technologies boost drug repurposing
Read more
The Bispecific Approach, Interviews with Merus, Genmab and NovalGen
Read more
Purespring to develop gene therapies for the kidney
Read more
Forbion to create and grow biotech companies
Read more
Real world evidence is changing regulatory policy
Read more
New treatments for amyotrophic lateral sclerosis
Read more
Using wastewater surveillance to control Covid-19
Read more
Transatlantic partnerships in life science
Read more
Pagination
Previous page
‹‹
Page 5
Next page
››
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form